
|Articles|July 30, 2021
- July 2021
- Volume 87
- Issue 7
July 2021 Interactives: Pet Peeves
Penny pinchers, early arrivals, and more are featured in this month's Pet Peeves.
Advertisement
Penny Pincher: Patient copay is $1 but they want you to try GoodRx.
Early Arrival: Patient asks for a transfer, you say 1 hour and they arrive in 15 minutes.
New Year, New Insurance: New year but "I have the same insurance" yet they did get a card in the mail...
What's bothering you? Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We'll share them here and in the publication.
Articles in this issue
over 5 years ago
OTC Product News: July 2021over 5 years ago
Rx Product News: July 2021over 5 years ago
Study: Women With CAD, Heart Disease Often Go Undertreatedover 5 years ago
How Does the EUA for the COVID-19 Vaccines Work?over 5 years ago
Lifestyle Changes Can Improve Inflammatory Burdenover 5 years ago
Training Program Helps Pharmacists Provide Diabetes Careover 5 years ago
July 2021 Interactives: Case StudiesAdvertisement
Related to this article

Inconsistent state immunization laws complicate pharmacy operations and limit patient access.

OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.

The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.

Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.

Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.

Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
3
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5

